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Until the middle of the 20th century, yaws was highly endemic and considered a serious public health problem in the Western
Paciﬁc Region (WPR), leading to intensive control eﬀorts in the 1950s–1960s. Since then, little attention has been paid to its
reemergence. Its current burden is unknown. This paper presents the results of an extensive literature review, focusing on yaws in
the South Paciﬁc. Available records suggest that the region remains largely free of yaws except for Papua New Guinea, Solomon
Islands, and Vanuatu. Many clinical cases reported recently were described as “attenuated”; advanced stages are rare. A single
intramuscularinjectionofbenzathinepenicillinisstilleﬀectiveincuringyaws.InthePaciﬁc,yawsmaybeamenabletoelimination
if adequate resources are provided and political commitment revived. A mapping of yaws prevalence in PNG, Solomon, and
Vanuatu is needed before comprehensive country-tailored strategies towards yaws elimination can be developed.
1.Introduction
Yaws is a nonvenereal infectious disease caused by the bac-
terium Treponema pallidum subspecies pertenue.I ti sm a i n l y
transmitted from person to person through direct contact
with exudates from early skin lesions of infected people
[1]. Yaws is considered a disease of poverty occurring in
tropical regions throughout the world with heavy rainfall
and high humidity [2]. It is more common in rural and
isolated populations where access to health care is often
limited [3]. Crowded environments and poor hygiene are
also considered as factors facilitating transmission [4, 5].
The disease aﬀects predominantly children younger than 15
years (the peak incidence of clinical manifestations is 2 to
10 years), who serve as the primary reservoir of the disease.
The current knowledge is that transmission is by direct
contact with infected lesions [2] and that ﬂies, including
nonbiting haematophagous ones, can infect skin breaches
through their dejecta or regurgitation [6, 7]. Perine et al.
[2] reported that a yaws-like treponema was identiﬁed in
African monkeys and baboons, and more recently Robed
et al. [8] mentioned that the genetic analysis of a strain
collected from a Guinean baboon demonstrated a close
relation to the human strains of yaws. Furthermore, yaws-
like infections have been identiﬁed in nonhuman primates
in Africa, in particular in the Republic of Congo where
17% of a wild gorilla population have been found with
typical yaw lesions [7] leading the authors to speculate that
yaws infections in gorillas and humans living in tropical
rain forests might be due to the same bacterium Tre-
ponema pertenue. Considering that in humans and gorillas
T. pertenue spreads by direct contact with infected lesions
[7] and that ﬂies also play a role in transmission of the
bacterium, a risk of contamination between humans and
other primates might exist. These ﬁndings argue in favor
of a potential role of yaws-infected nonhuman primates in
humans’ infections. However, there is no evidence of such
transmission in the literature, and the actual signiﬁcance
of these ﬁndings to human is not known [2, 3, 9]. This
debate is interesting and certainly deserves more research to2 Journal of Tropical Medicine
establish if pathogens cross-transmit between humans and
primates populations. Nevertheless, for the Western Paciﬁc
Region,wedidnotﬁndevidenceofrecentresurgenceofyaws
in countries where frequent encounters between humans
and monkeys occur (Cambodia, Malaysia, or Vietnam, e.g.),
but we found evidence of recent yaws reappearance in
Paciﬁc countries where there is no population of nonhuman
primates. Furthermore, India which hosts a large population
of monkeys with frequent encounters with humans managed
to eliminate yaws. Therefore, the provocative question of
whether humans are in fact the reservoir of the disease to
other primates might be raised. In the absence of nonhuman
primates in the Paciﬁc, humans are the only known reservoir
of the disease in this part of the region.
It is estimated that there were 50 to 150 million cases
of active yaws worldwide in the early 1950s [3]. A global
campaign to control endemic treponematoses, including
yaws, was launched in 1952 targeting 46 countries [10]. By
the end of 1964, the global campaign, supported by the
World Health Organization and the United Nations Chil-
dren’s Fund, successfully reduced the prevalence of yaws
by 95% to an estimated 2.5 million cases [4, 10–12].
Yaws surveillance and control activities subsequently became
integrated into the primary health care systems of individual
countries, where remaining cases were to be identiﬁed and
treated [10]. Yaws transmission persisted, however, although
atlowlevels,andthepassiveapproachforyawscontrolunder
primary health care systems was not eﬃcient in detecting
and treating cases remaining in remote and isolated areas of
developing countries. In the 1970s, resurgence was reported
in many of the formally endemic areas [10]. Despite eﬀorts
to renew the commitment to yaws control and to reengage
the international community (e.g., World Health Assembly
Resolution 31.58 of 1978 on yaws; global and regional
meetings in the early 1980s), yaws persisted in many parts
of the world, with the largest number of cases found in west
and central Africa [13, 14].
In the South Paciﬁc, records show that yaws was highly
prevalent prior to mass treatment campaigns carried out in
thelate1950sandearly1960s[15].Followingmasstreatment
campaigns, the number of reported cases dramatically
declined, and yaws was considered eliminated in most areas
of the South Paciﬁc [16, 17]. Since the late 1970s, however,
suspected cases of yaws were reported in various areas of
PapuaNewGuinea(PNG)[18–23],theSolomonIslands[16,
24–26], and Vanuatu [17, 27, 28]. While available records
suggest that these countries remain endemic to this date, the
extend of the current burden due to yaws is not well known
[9].
In our twelve-year experience as a ﬁeld public health ex-
pert in the Paciﬁc, we had to deal with yaws in many in-
stances. Over the years, we spent time doing literature re-
searches to address, when they aroused, speciﬁc issues linked
to yaws control activities in the Paciﬁc, and we often felt
that a single document providing all available information
together with relevant references would be useful to clin-
icians and to health workers. In the past three decades,
yaws control activities have been localized in a number of
areas in the Paciﬁc, and there is an obvious disconnect
between regular ﬁeld observations of yaws coherent with
verbal reports from front line health workers mentioning
that yaws has never stopped or has reappeared in the past
few decades and the patchy and scarce information found
in the literature. There is no document providing an overall
picture of the current yaws situation in the region, and
the literature consulted over the years gave the impression
that most activities have been conducted in silos, answering
to a sudden and localized resurgence or interest on yaws.
Discussions with colleagues and health workers conﬁrmed
this overall sense of a heterogeneous approach in the region
and the lack of a clear idea of the current situation in regards
to a disease that has supposedly been eradicated more than
half a century ago but that is regularly encountered in certain
parts of the region. It then became clear that a review of all
theavailableinformationandreferencesfortheregionwould
beausefultoolnotonlytocliniciansbutalsotopublichealth
decisionmakers.Athoroughassessmentoftheyawssituation
in the Western Paciﬁc Region (WPR) over the past 60 years
and the potential challenges yaws eradication poses today
could serve as a reminder for the public health community
in the region about this neglected disease. It could stimulate
a discussion among regional public health decision makers
and pave the way for a coordinated approach in the areas
still aﬀected. With this in mind, we reviewed the literature
currently available, and we provide in this paper a summary
ofepidemiologicalrecordsonyawsintheWPRwithaspecial
focus on the Paciﬁc area since the 1980s. It also reviews past
control eﬀorts in the region with an emphasis on PNG, the
Solomon Islands, and Vanuatu.
2.MaterialsandMethods
In addition to data provided by WHO Member States, we
searched on MEDLINE and WHOLIS, the World Health
Organization’s library database, for relevant articles using
the term “yaws.” To identify references speciﬁc to the region
(primarily South Paciﬁc), the following terms were used:
“SouthPaciﬁc,”“Paciﬁc,”and “WesternPaciﬁc”forcountries
outside the Paciﬁc, and individual country names. Articles
published through 27th December 2010 were included. A
similar search using the same words was conducted on
WHOLIS.
We ﬁrst reviewed titles and abstracts and then selected
articles to be fully reviewed. Some articles from the 1950s
to the 1970s in particular were excluded due to the contents
being too similar to the ones already referenced or because
they were quoted in more recent articles. The whole process
identiﬁed 53 relevant documents, all of which are referenced
in this paper.
Anadditionalsearchwith“endemictreponematosis”and
with “endemic treponematoses” was conducted which found
300 references. The search was then limited to “Western
Paciﬁc,” “Paciﬁc,” “Asia,” and individual country names in
the region together with the term “endemic treponematosis”
or “endemic treponematoses.” Only two additional relevant
articles were found but were excluded for similar reasons to
those explained above.Journal of Tropical Medicine 3
3. Results andDiscussion
3.1. Past and Current Yaws Control Strategies in the
South Paciﬁc Region
3.1.1. Past Eﬀorts. Yaws control during the 1950s and 1960s
put a strong emphasis on assessing the population-level
prevalence of active and infectious yaws cases. Initial surveys
often covered a large proportion of endemic populations and
were conducted together with mass or selective treatment
using procaine penicillin G with 2% aluminum monos-
tearate (PAM) [15]. For example, in the Cook Islands, 99%
of the population were screened in 1960, and in Vanuatu,
an initial mass treatment survey conducted in 1958 covered
94% of the indigenous population [15]. The results of these
surveys were also utilized to determine appropriate control
methods. In most cases, further surveys were conducted to
identify and treat previously untreated cases and their con-
tacts [15]. The national control programs were established
with the assistance of WHO and UNICEF in most areas of
the South Paciﬁc and received technical assistance from an
Interregional Treponematosis Advisory Team consisting of
a medical oﬃcer, a serologist, and a nurse/administrative
oﬃcer based in the region, in particular for training of
national staﬀ members in conducting surveys and diagnostic
techniques [29]. Surveys conducted in the 1960s and 1970s
showed successful reduction of yaws below detectable levels
in most areas of the South Paciﬁc. For example, Geizer
reported [15] that only 6 cases were found in Niue in 1957,
while the disease was widely spread earlier. According to
Geizer, only 3 cases were diagnosed between 1964 and 1984
in Fiji, the last one being in 1983, while initial surveys
conducted in 1954 found 10% to 70% prevalence of reactive
serology. In Tonga, the last 7 cases were reported in 1976
while 7,452 cases were reported in 1962 when the eradication
campaign was launched. Several authors reported that yaws
control activities were then gradually integrated with other
communicable disease programs into basic health services
without providing further details [3, 9, 30]. In 1985, Meheus
[31] and Hopkins [32] discussed integration of yaws control
activities into Primary Health Care (PHC) interventions.
Meheus explains that control of yaws was then relying on
several strategies combining population screening with mass
treatment, and case ﬁnding/diagnosis at consultation with
contact tracing/treatment. In addition, professional training
and health education were conducted. We did not ﬁnd
concrete examples on how these yaws control activities
were introduced, implemented, and integrated in the South
Paciﬁc.
Lack of funding associated with weak political commit-
ment and fragile primary health care systems resulted in the
continued occurrence of yaws and its poor reporting [9]. By
the 1970s and 1980s, sporadic outbreaks were reported in
PNG, the Solomon Islands, and Vanuatu, and in most cases,
the immediate responses to these outbreaks were recorded
andpublished.However,asGeizerdiscussed[15]in1986,in-
formation on yaws became scarce once the outbreaks were
contained, and very limited information about surveillance
activities is currently available for these countries.
3.1.2. Recent Approaches to Yaws Control. In 1984, the WHO
recommendations were published [2] in response to resur-
gence in the 1970s. According to the recommendations, a
treatment strategy for yaws control should be based on the
prevalence of clinically active yaws. Thus, the prevalence of
active case needs to be assessed in a representative sample of
a population of interest (e.g., district, province, or country)
in order to determine an appropriate treatment policy for
the population. The recommendations also suggest that
treatment of the entire population (total mass treatment),
treatment of all active cases and obvious contacts (contacts
being deﬁned as those who have frequent, direct, person-
to-person contact with a patient with active yaws lesions)
as well as all children under 15 years of age (juvenile mass
treatment), or treatment of all active cases and all household
andotherobviouscontacts(selectivemasstreatment)should
be adopted based on the level of prevalence of clinically
active yaws in the community (Table 1). In addition, it was
indicated that in remote areas where access to health services
is limited, total mass treatment may be a more appropriate
optionevenwhenthepopulationprevalenceislessthan10%.
Benzathine benzylpenicillin was recommended in pref-
erence to the other forms of penicillin, penicillin aluminium
monostearate (PAM) in particular as the serum concentra-
tion of penicillin produced by benzathine benzylpenicillin
persists above the treponemicidal level much longer than
that produced by PAM [2]. The following dosages were
recommended:
(i) 600.000 units for children below 6 years;
(ii) 1.2 million units for children between 6 and 14 years;
(iii) 2.4 million units for children above 14 years and
adults.
These recommendations are still applicable today for the
control of yaws, and the same treatment using a single
dose of benzathine penicillin is still considered the standard
treatment for yaws [33]. Tetracycline, erythromycin, or
doxycycline can be used for patients with penicillin hyper-
sensitivity [10].
To be successful mass treatments must reach a very high
level of coverage. While no studies we reviewed speciﬁed the
minimum level of coverage to be targeted, Hudson et al.
[34] argued that the successful eradication campaigns in the
1950s and 1960s can be in part attributed to the fact that
the treatment of the entire treponemal reservoir, including
active and latent cases, was achieved. Perine et al. [2] stated
that “all contacts of infectious cases must be treated if yaws
is to be eliminated from the community” and estimated
that 1 to 3% of yaws-aﬀected patients may not be cured by
the recommended treatment due to quality issues with the
penicillin used or the use of altered penicillin associated with
improper storage, reconstitution, or expiration of drugs.
While mass treatment is challenging in terms of logistics
and requires high political commitment [17], the low cost
of benzathin penicillin and its eﬃcacy make it a valuable
option for treating yaws in a population. De Noray et al.
[17]estimatedthecostofthe2001masstreatmentconducted
in SANMA province, Vanuatu, to be USD 1.30 per person.4 Journal of Tropical Medicine
Table 1: WHO recommended treatment strategy by disease prevalence [2].
Approximate prevalence of clinically
active yaws in the community Endemicity classiﬁcation Recommended treatment
High (>10%) Hyperendemic Entire population of the community (total mass treatment)
Medium (5–10%) Mesoendemic All active cases, all children under 15, and obvious contacts (juvenile
mass treatment)
Low (<5%) Hypoendemic All active cases and all household and other obvious contacts
(selective mass treatment)
Table 2: Estimating seroreactor prevalence from population preva-
lence [2].
Percentage of population with
active yaws Percentage of seroreactors
1-2 8.5
11–15 54.0
16–20 71.0
21–30 77.5
Treatment with penicillin always carries the risk of severe
side eﬀects such as anaphylactic shock, and this must be
considered when planning such interventions [2, 17].
BasedontheWHOrecommendations,serologicaltesting
is necessary to identify latent or incubating cases. However,
in some cases, serological testing during a prevalence survey
may not be necessary, since most latent or incubating cases
are found in clusters near an infectious case [2]. These
would receive treatment as household or obvious contacts
(even if they were not identiﬁed as cases). Perine et al.
[2] indicated that the prevalence of active yaws observed
during a survey could be used to estimate the prevalence of
seroreactor deﬁned as seroactive yaws cases. Whether or not
these estimations apply to the current epidemiology of yaws
is not well understood (Table 2).
Most yaws control activities implemented in the South
Paciﬁc since the 1990s followed the above-recommended
strategiesandtreatmentregimen.However,in2010, Feganet
al. [28] raised a question on the use of benzathin penicillin,
mainly because of its logistical constraints. The same authors
suggested exploring the possibility of using an oral treatment
such as azithromycin, a macrolide antibiotic with a known
eﬃcacy in T. pallidum infections and with a long half-life
in tissue. Compared to the challenges posed by treatments
with benzathine penicillin (logistics, possible allergy, and
pain associated with the injection), azythromycin presents
some true advantages. Its oral presentation and its eﬃcacy
in single-dose administration for the treatment of syphilis in
adults [35] make it potentially a more accessible and more
acceptable treatment at peripheral level. However, some
reservations must be considered. First, macrolide-resistant T.
pallidum initially identiﬁed in groups with high-risk sexual
behavior in the United States and Ireland [36]h a sn o wb e e n
isolated in other countries such as China where Martin et
al. [37] report an apparent high prevalence of macrolide
resistant T. pallidum in Shanghai, the Czech Republic where
the prevalence of the mutations responsible for macrolide-
resistance is reported to be as high as 20% in clinical spec-
imens [38] or in Canada where 29% of syphilis cases were
foundtobecausedbyastrainresistanttoazythromycin[39].
The recent identiﬁcation of macrolide-resistant T. pallidum
subspecies pallidum in several countries raises concerns on
the possible independent emergence of multiple strains and
on the role selective pressure and other conditions may have
played. Furthermore, it raises questions on the impact of
these ﬁndings on other subspecies of Treponema pallidum
including pertenue. It also allows speculations that similar
mutations leading to macrolide resistance might quickly
appear with yaws bacterium. These reservations and the
consistent success of penicillin in the treatment of syphilis
and yaws for more than ﬁfty years strongly argue in favor of
benzathine penicillin as the treatment of choice for yaws.
In 1998, following a study in 39 children with clinical
yaws in Karkar Island, PNG, Backhouse et al. [22]r e p o r t e d
that while initial clinical and serologic responses to benza-
thine penicillin were satisfactory in more than 90% of the
children, 11 (28%) later showed clinical and/or serologic
evidence of relapse or reinfection. These authors concluded
in favor of treatment failures due to reduced susceptibility to
penicillin because reinfection was unlikely in this particular
community and under the circumstances of the study. To
our knowledge, this possible reduction in susceptibility or
tolerance to benzathine penicillin of T. pallidum subsp.
pertenue has not been further documented, and additional
data to support the ﬁnding could not be found in the South
Paciﬁc.
3.2. Diagnosis of Yaws in the South Paciﬁc. In most cases, di-
agnosis was based on clinical criteria during the 1950s and
1960s [15]. With the disappearance of yaws in a number
of countries and the progressive retirement of those who
were involved in the eradication campaigns in the 1950s and
1960s, some authors [34] suggested that most health workers
have never seen the disease and may not be able to make a
clinical diagnosis. However, our review shows that yaws has
been most often detected clinically by primary health care
workers, for example, in Vanuatu in 2000 [17]a n dP N G
in 1995 [23], who then reported to their local authorities,
leading to further investigations and control activities. It is
also possible that some of those workers had been involved
in the past or more recent control eﬀorts and were capable
of recognizing the symptoms. On another hand, a number of
skin conditions common in the tropics may appear similar
to yaws lesions, and thus, it is possible that some proportionJournal of Tropical Medicine 5
of yaws reported in primary health care settings may in fact
be false positive cases. In some instances, clinically identiﬁed
cases were conﬁrmed serologically. Nevertheless, clinical di-
a g n o s i sm a d ei nr e c e n ty e a r sm a yb el e s ss p e c i ﬁ ca st h e
number of primary health care workers experienced in yaws
diagnosis is declining, and a large number of active cases
identiﬁed in recent years are reported as presenting milder
symptoms compared to the 1950s [18, 28, 40]. One can
speculate about the accuracy of this contention, especially as
there is nearly no survey available comparing results of yaws
clinical studies in the same area in the 1950s and nowadays.
However, for the Western Paciﬁc Region, we found one
survey[16]wheretheauthorscompareclinicalﬁndingsfrom
two surveys conducted in 1953 and in 1987 in the same
island of the Solomon Islands and found 10% of cases with
secondary or tertiary yaws in 1987 compared to 30% in
1953.Thereasonsfortheseattenuatedclinicalmanifestations
are unclear, but they are likely the consequence of a mix
of diﬀerent factors such as more accessible health systems
possiblyresultinginearlierdiagnosisofinfectionsandawide
useofantibiotics(especiallypenicillinsincethe1950s)which
might delay the occurrence of clinical lesions.
Common serological tests currently used in the South
PaciﬁcaretheVenerealDiseaseResearchLaboratory(VDRL)
test and the Rapid Plasma Reagin (RPR) test. Both are
sensitive, but they are nontreponemal antigen tests and do
not diﬀerentiate yaws from other treponemal infections such
as syphilis [2, 4]. However, it is important to acknowledge
that treponemal tests such as the ﬂuorescent treponemal
antibody-absorption enzyme immunoassay (FTA-ABS), the
Treponema pallidum particle agglutination (TPPA) test, or
the enzyme immunoassay (EIA) cannot make such a distinc-
tion either. This reality can be of importance as it represents
a particular challenge in countries where both yaws and
syphilis are endemic. For example, a question was raised
regarding the speciﬁcity of the RPR test in Vanuatu where
surveys in 2000 found an unexpected syphilis prevalence
of 2.4% in antenatal clinics women (RPR conﬁrmed by
TPHA).Oneoftheauthors(C.Capuano)wasinvolvedinthe
discussion, which concluded that in the absence of clinical
symptoms, it was not possible to diﬀerentiate among the
two infections (personal communications Dr. C. Capuano,
2001). Similarly, the inability to serologically diﬀerentiate
yawsandsyphiliscanbeanissueincountrieswhereyawswas
endemic in the past, and the prevalence of syphilis is known
to be high. In 1992, Gershman et al. [41] also raised the issue
following a large increase of serologically reported cases of
syphilis in the Marshall Islands, a previously yaws endemic
country where it was believed to have been eradicated in
the late 1940s and early 1950s. New techniques such as the
molecular methods reported in 2006 by Centurion-Lara et
al. [42]t od i ﬀerentiate the three T. pallidum subspecies could
be of great assistance in similar situations. However, such
methods are expensive, complex, and they require more than
the standard laboratory equipment found in the resources-
limited countries still aﬀected by yaws in the WPR. These
constraints make such methods currently not aﬀordable and
of limited value for ﬁeld use.
However, although prevention of yaws and syphilis is
very diﬀerent, both infections warrant treatment regardless
of the ability to diﬀerentiate them. Thus, one can expect that
in the WPR, diagnosis of yaws will continue to require the
assessment of test results and clinical manifestations while
carefully taking into account epidemiologic characteristics of
yaws.
3.3. Yaws in Papua New Guinea. A nationwide mass treat-
ment targeting the entire population of PNG took place
between 1953 and 1958 under the Australian administration
covering more than 90% of the population [20]. Many of the
untreated individuals were residents of remote and isolated
areas of the country where campaign reach was limited. The
campaign was successful; only 2,352 cases were reported in
1959, and fewer than 500 cases were reported each year until
1973. A slight increase in the number of cases was recorded
between 1973 and 1978. However, it did not exceed 1,000
cases per year [19],and most of them occurred in rural areas,
in Bougainville, and around Rabaul in New Britain [18]. The
disease was rare in the Highland districts and reported to be
nonexistent in the Central Province and Port Moresby [40].
Consequently, yaws was removed from the national list of
reportablediseases.Theclinicalappearanceofyawsobserved
during this time period was milder (fewer lesions, plantar
lesions, and bone involvement rarely observed) than in the
1950s, and these milder cases were described as attenuated
cases [18, 40].
In 1964-65, a serological survey for treponemal disease
involving 844 sera was conducted in the Eastern Highlands
of PNG [43]. No clinical case of active yaws was found
in the population, but some of the elderly were identiﬁed
with clinical evidence of old yawslesions. The seroprevalence
reported by the authors varies from 3.9% to 79.2%. In 3 out
of the 10 census units surveyed, the prevalence in children
below 15 years ranged from 14.3% to 40%, and the authors
concluded that the treponemal disease involved was yaws.
In December 1978, a mass campaign targeting the entire
population was carried out on Karkar Island, Madang Prov-
ince, after a rapid increase of yaws cases was recorded in
the previous year [18]. Based on surveys carried out pre-
ceding the mass treatment, the estimated prevalence varied
from 0% to 27%, and the prevalence of infectious cases
(examined using dark-ﬁeld microscopy) also varied from
2% to 22% on the island. Although the mass treatment
reportedtohavecoveredabove90%oftheislandpopulation,
the island continued to report cases of yaws. In 1981,
a more comprehensive survey reported 0.36% prevalence
of infectious cases and 2% prevalence of noninfectious
clinical cases in the surveyed villages. Cases with attenuated
manifestation were also recorded during this outbreak, and a
local doctor also noted that the response to PAM was poorer
thaninthe1950s.Itispossiblethatpenicillinwasimproperly
stored and thus lost its potency.
In the early 1980s, clusters of cases were reported in the
Provincesof EastandWestSepik, EastandWest New Britain,
New Ireland, and Milne Bay. The outbreak and following
mass treatments in Yilui village, West Sepik Province, is6 Journal of Tropical Medicine
well documented [19]. In Yilui village (population 509
based on 1980 census), the initial mass treatments in early
1984 found 193 clinical cases (more than 35% of the 1980
population). A follow-up treatment conducted six months
later found 60 clinical cases, mainly children, including 49
clinical cases treated during the initial mass treatments.
Serological tests were performed on a sample of clinical
and nonsymptomatic individuals. A large proportion of
nonsymptomatic individuals presented reactive VDRL tests
(12 out of 19), suggesting that a large proportion of the
village population had been exposed to the infection in the
recent past, just prior to the mass treatments. Cases with
attenuated symptoms were also reported in Yilui. In the
Kiriwina and Trobriand Islands of Milne Bay Province, a
small number of suspected cases among children aged 4 to
13 were reported in 1984 [21]. Approximately, 70% of the
suspected clinical cases were serologically (VDRL) positive.
No case presented the late stage of the disease.
In 1988, another outbreak was reported on Karkar Island
in the village of Takia (population 1600) [22]. Among 632
children aged 0 to 15 years, 39 (6%) presented early lesions.
All villagers were subsequently treated with benzathine pen-
icillin.Bloodsampleswererepeatedlycollectedfromtheclin-
ical cases over 22 months following the initial treatment, and
the authors found that 13% of the cases remained or became
serologically positive again at 22 months despite the fact that
many of the initial cases were treated multiple times. Clinical
relapse among the initial clinical cases was reported to be
8% at 22 months. This incidence suggested that yaws cases
in this area had decreased sensitivity to penicillin. However,
the ﬁnding needs to be conﬁrmed.
Between April 2000 and September 2001, the Nine Mile
Clinic in Port Moresby identiﬁed 494 cases conﬁrmed by
serological tests (TPHA and VDRL) through clinic-based
case detection [23]. The clinic serves approximately 20,000
individuals in the periurban population of northeast Port
Moresby, where many live in squatter settlements with poor
access to water and electricity. Yaws cases were seen at the
clinicasearlyas1995,andayawsregisterwascreatedinApril
2000 after an increase in numbers was observed in 1999.
The clinic also conducted a prevalence survey in 2001 at
settlements near the clinic where prevalence was expected to
be high. Among 227 children under the age of 17 examined,
33 had active yaws lesions as diagnosed by experienced
medical staﬀ. It is not clear whether these cases were later
treated. Yaws cases had been rare in Port Moresby, and thus,
this ﬁnding suggests that the cases observed at the clinic may
have contracted yaws outside Port Moresby or from persons
withyawswhomigratedfromotherpartsofthecountry.The
population in Port Moresby is young and rapidly growing
with a continuous migration of people throughout the
country. With poor hygiene, crowded environments, and a
large number of people previously unexposed to yaws, the
population provides an ideal environment for yaws trans-
mission [23].
Records on yaws in most areas of PNG are not available
since the late 1980s. Therefore, it is diﬃcult to assess the
current distribution of the disease. However, as found in
Port Moresby in 2000 and 2001, cases exist and transmission
is still likely to be active. Our paper suggests that active
transmission is currently occurring in various parts of PNG.
However, it is important to note that no late-stage cases
have been seen since the mass treatment in 1950s and many
of the more recent cases presented with a small number
of lesions. Table 3 summarizes yaws reported cases and
prevalence surveys in PNG from 1959 to 2001.
3.4. Yaws in Solomon Islands. An a t i o n w i d em a s st r e a t m e n t
campaign was carried out in the British Solomon Islands
Protectorate between 1956 and 1958, covering all main
islands and most of the other inhabited islands. An initial
survey prior to the treatmentcampaign found the prevalence
of active yaws cases above 14.5% [25]. The campaign was
successful, and only a few cases were reported (from Malaita)
following the campaign. The national yaws elimination
project was then completed in 1963. A small number of cases
were sporadically reported until 1970.
No cases were documented from 1970 until 1981 when
an outbreak of cases was reported in the Western Province
[16, 24, 44]. The cases were initially misdiagnosed as tropical
ulcers until suspected cases presenting large leg ulcers were
serologically conﬁrmed as yaws in 1984 (serology done in
Australia). Following the conﬁrmation, a mass treatment of
the entire population was carried out in the islands of Gizo,
VellalaVella,Ranonga,Simbo,NewGeorgia,Kolombangara,
andNorthChoiseul.Bytheendofthecampaign,3,994outof
29,235 persons examined (13.7%) were found to have active
yaws [25]. The disease was more prevalent among children
undertheageof15;28%ofchildrenunder15examinedwere
diagnosed to have yaws [24]. Yaws was diagnosed clinically
in the ﬁeld by medical staﬀ involved in the previous mass
campaign in the 1950s. Follow-up visits in selected villages
did not ﬁnd any additional cases. A higher prevalence was
reported in the islands of Vella la Vella, Ranonga, and Simbo.
No case had been reported in the Shorthand Islands, despite
its proximity to PNG [25].
In 1986, monthly reports from rural health clinics in-
dicated a recurrence of yaws in areas of Western Province
treated during the 1984 mass campaign. A sample survey
was conducted in areas where a large number of cases were
reported [16]. 83 deﬁnite cases (10%, papillomatous or
ulceropapillomatous) and 68 suspected cases (8.2%, scanty
macules and maculopapulomatous) were identiﬁed among
833 examined. Based on this ﬁnding, a treatment campaign
was carried out in 1987 on the islands of Vella la Vella,
Ranonga, Simbo, Kolombangara, New Georgia, and Gizo.
Among the total of 24,216 persons treated, 2070 (8.5%) had
clinical manifestations. Blood was collected from a random
sample of the population, and 11% of 453 serum samples
showed positive VDRL tests. In Simbo Island, where 47% of
treatedindividuals(580of1,220)wereclinicallydiagnosedto
have yaws, 57% of cases presented primary lesions (a single
raised lesion, often ulcerated), while 43% had secondary
lesions (multiple ulcers and small papillomas). The majority
of cases were under 15 years of age. Investigators also noted
that cases in 1984 and 1987 presented milder attenuated
symptoms (a few scanty lesions) than cases in 1950s whoJournal of Tropical Medicine 7
Table 3: Summary of yaws reported cases and prevalence surveys in PNG since 1959.
Area Year Prevalence N∗ Activity type Reference
All areas 1959-60 2352 cases — Reports Garner et al., [19]
Eastern highlands 1964-65 29.3% 844 Serological survey Garner and Hornabrook,
[43]
All areas ∼1973 Fewer than 500 cases
annually
— Reports Garner et al., [19]
All areas 1973–78 500∼1000 cases annually — Reports Garner et al., [19] Reid,
[18]
Karkar Island, Madang
Province 1978 Clinical 0–27%
Infectious 2–20%
∼1800 Preliminary survey prior
to mass treatment Reid, [18]
Karkar Island 1978 Clinical 4.7% —
Mass treatment of
92–95% of Karkar Island
population
Reid, [18]
Karkar Island 1981 Infectious 0.36%
Noninfectious 2%
—
Survey conducted in
randomly selected
villages
Reid, [18]
Yilui village, West Sepil
Province 1984 204 clinical cases —
Screening concurrent
with mass treatment of
all villagers
Garner et al., [19]
Kiriwina Island, Trobriand
Island 1984-85
34 suspected cases
3 3o u to f4 9b l o o d
specimen were VDRL
positive
— Cases reported from
health centers Duncan and Alto, [21]
Marup village, Karkar
Island, and Madang
Province
1988 Early lesions 6% 632
Survey of children
(0–15yo) following
outbreak, followed by
mass treatment of all
villagers Report of
decreased sensitivity to
penicillin
Backhouse et al., [22]
Periurban settlements of
Port Moresby 2000-01 494 clinical cases — Cases detected at the 9
Mile Clinic Manning and Ogle, [23]
Periurban settlements of
Port Moresby 2001 Clinical cases 14.5% 227
Children under 17 at
four settlements
(convenient samples)
near the 9 Mile Clinic
Manning and Ogle, [23]
∗The number of persons examined/screened.
often presented with abundant large elevated papillomas.
While tertiary yaws was common in the 1950s, it was not
observed during the campaign in 1987.
No documents recording yaws between 1988 and 1998
seem to be publicly available. The Annual Health Report of
2007 compiled by the Ministry of Health provides some
evidence of persistent foci existing in the country for the last
decade [26].
Between 1998 and 2007, all 10 provinces reported cases
of yaws, detected among patients attending primary health
care facilities. No survey or mass treatment were reported
to have been carried out since 1987. According to the
report, the national incidence rate of yaws in 2007 estimated
using the 2007 projected population of the Solomon Islands
was reported to be 39 per 1000 person-years. Yaws cases
accounted for 2% of all primary health care attendees in
2007. The incidence rate in 2007 was high in Makira (70.4
per 1000) and Guadalcanal (60.3 per 1000), and low in Isabel
(19 per 1000) and Choiseul (17 per 1000). Based on the
reported incidence rates and the 2007 projected provincial
population [26], the absolute number of cases in 2007 was
estimated to exceed 4,000 in Guadalcanal and Malaita. The
disease incidence seems to have decreased nationally since
1998. However, the rates have ﬂuctuated in the past, and
the observed change in the rates may be due to changes in
diagnosis and recording practices over the 10 year period. In
2007, a WHO consultant [45] noted that for the period from
1997 to 2006 the rate of clinical yaws reported was constantly
highestinchildrenagedbetweenoneandfouryears,andthat
in 2003, the rate increased with a marked rise in children
and people aged ﬁve years and over. Since 2003, the rate has
shown a downward trend, reaching its lowest point in 2006.
There is no clear explanation for the increased rate observed
in 2003.
It is also noted that cases of yaws are reported entirely
on clinical grounds. In addition, data gathered since 1998
only include cases diagnosed in primary health care facilities.
The ﬁgures may be overestimated if cases are misdiagnosed8 Journal of Tropical Medicine
or overdiagnosed, or underestimated if many yaws cases do
not seek care from the health system.
In 1984 and 1986, a woman in Australia who migrated
from the Solomon Islands in 1975 was treated for tertiary
stage yaws [46]. She visited the Solomon Islands in 1981 and
suﬀered from likely secondary-stage yaws upon her visit. The
authors speculated that she may have been reinfected during
the visit leading to the destructive bony lesions consistent
withatertiarystageofyawsobservedin1984and1986.There
has been no other report of imported yaws from the South
Paciﬁc in Australia or New Zealand.
As indicated by the 2007 national health report [26], it is
likely that yaws is still found in most of the provinces in the
Solomon Islands. However, more information on reported
clinical cases, such as detailed descriptions of symptoms
and serological status, is necessary to conﬁrm whether the
reported cases are true cases of yaws, and to identify the most
aﬀected areas.
Table 4 summarizes yaws reported cases and prevalence
surveys in the Solomon Islands from 1956 to 2007.
3.5. Yaws in Vanuatu. In Vanuatu, the ﬁrst mass campaign
began in 1958. An initial survey treated approximately 94%
of the resident population, and a followup was estimated
to have covered 92% of the population [15]. About two-
thirds of Tanna Island in the province of TAFEA was not
treated during the initial treatment surveys due to refusal
for political reasons [15]. The campaign was successful as
conﬁrmed by a survey in 1961. The estimated prevalence
after the mass campaigns was reduced to 0.5 per 1000.
Throughout the 1970s, fewer than 100 cases were re-
ported each year. In the late 1970s, an increase in cases in
Tanna Island was reported. Further investigation of these
cases revealed active yaws transmission in the island.
In 1981 and 1985, mass treatments were carried out in
several villages in northwestern Tanna where clinical cases
had been reported. Despite these eﬀorts, yaws continued to
reappear in Tanna, and a large-scale treatment campaign
was planned in 1989. A survey conducted prior to the mass
treatment found 116 (16.5%) clinically suspected cases out
of 704 treatment participants in 13 villages and 1 school
in Tanna [27]. Among the 97 clinically suspected cases, 34
showed VDRL titer above 1:4. Based on this ﬁnding, the
mass treatment was planned to cover the entire population
of Tanna, about 20,700 people. Approximately 90% of the
population were treated, although children under the age of
3 months were excluded from examination and treatment.
During the mass treatment, 348 clinically suspected cases
were recorded. A large proportion of clinical cases (79.3%)
were under the age of 15, and 32% of blood samples from
189suspectedcaseshadpositive VDRLresults.Followingthe
campaign, only a few cases were reported in 1990. However,
by 1992, a number of cases were reported from villages that
previously had not participated in the treatment campaign.
Thelaboratoryreportsbetween1995and1998alsoindicated
that yaws was still not eliminated from the island [47].
In 2000, patients with suspicious lesions were reported
on the island of Santo, SANMA province, where laboratory
records showed no conﬁrmed cases between 1995 and
1998. A preliminary investigation found 21 clinical cases
in Central and South Santo including 20 cases serologically
conﬁrmed as yaws. From May to July 2001, a sample survey
representativeoftheentireislandwasconducted.Among273
individuals, 57 (20.9%) were serologically positive [47]. The
majority (70%) of seropositives were males, and 40% were
under 15 years of age. Following the survey, a mass treatment
of the entire SANMA Province was carried out. People of all
ages were eligible for treatment by benzathine penicillin. A
total of 36,414 persons in SANMA Province were treated.
The treatment coverage was estimated to be 92.4% based
on the campaign registers and exceeded 100% based on the
census population of 1999. During the treatment campaign,
251 clinically suspected cases were found and treated in 82
villages. A large proportion of clinical cases (78%) were
under 15. Among suspected clinical cases who were later
serologically tested, 40% (96 out of 230) had positive VDRL
results. It was also noted that cases were concentrated in
central and southern parts of the province.
The total estimated cost of the 2001 eradication cam-
paign in SANMA Province reached USD 41,700 for a
population of 36,414 or an estimated USD 1.15 per person
[17].
In 2007, 789 cases were reported on a routine health
report from the island of Tanna. A serological and clinical
survey using a cluster sampling method was conducted
in 2008 to assess the endemicity of yaws on this island.
Among 306 individuals from whom blood samples were
taken,95(31%)werepositivesforrapidplasmareagin(RPR)
and/or rapid diagnostic test for syphilis (RDT). It is not
stated whether the seropositive individuals showed clinical
manifestationsofyaws,hadbeentreatedforthediseaseinthe
recent past, or are active cases of yaws.Out of 473 individuals
enrolled in the clinical survey, 55 (11%) had typical yaws
lesions. All were below 15 years of age. Sixty six (14%) had
skin lesions which may possibly have been yaws, and most of
them (94%) were below 15 years of age. During this survey,
onlyonetertiarycaseofyawswasseeninanadult,presenting
with a mild saber tibia [28].
All cases reported since the 1970s were found in clusters
on certain islands of TAFEA and SANMA Provinces. Follow-
ups of treated cases could ensure prevention of further out-
breaks. Active case detection and appropriate treatment may
be necessary in some communities where a large number of
cases were previously reported. Yaws has not been oﬃcially
reported in the other provinces since the mass treatment
campaigns in the late 1950s. However, the current situation
has not been assessed and is unknown.
Table 5 summarizes yaws reported cases and prevalence
surveys in Vanuatu from 1958 to 2008.
3.6. Yaws in Other Areas of the South Paciﬁc. With the tech-
nical assistance of WHO and UNICEF, national yaws control
programs were established in Fiji and Western Samoa
(Samoa) in 1955, Gilbert and Ellice Islands (Kiribati and
Tuvalu) in 1957, and Tonga in 1962. Initial surveys con-
ducted by these national programs showed a varying degree
of yaws endemicity in the region with the highest prevalenceJournal of Tropical Medicine 9
Table 4: Summary of yaws reported cases and prevalence surveys in Solomon Islands since 1956.
Area Year Prevalence N∗ Activity type Reference
All main islands and
most of inhabited
islands
1956–58 Active 14.5%
Infectious 2.9%
112, 700
(estimated)
Screening concurrent
with whole
population mass
treatment
Alemaena, [25]
Western Solomon
Islands
Late
1960s–1970
Unconﬁrmed cases
reported —— A l e m a e n a , [ 25]
Western Province 1984 Active 13.7% 29,235
Screening concurrent
with mass treatment
of Western Province
Cases reported in
Vella la Vella,
Ranonnga, and Simbo
Alemaena, [25]
Australia 1984 — —
Case study of
immigrant woman
with tertiary yaws
from Solomon Islands
Wallace and Ellis, [46]
Western Province 1986
Deﬁnite yaws1 10%
Suspected yaws2
8.2%
833
Sample survey,
representative of Vella
la Vella, Ranonga, and
Simbo
Fegan et al., [16]
Western Province 1987
Active 8.5%
11% of 453 cases
was VDRL positive
24,216
Screening concurrent
with mass treatment
of Western Province
(except Choiseul)
Fegan et al., [16]
All areas 1998 59.1 per 1,0003 Clinic/hospital
reports MOH, Solomon Islands, [26]
All areas 1999 49.5 per 1,000 Clinic/hospital
reports MOH, Solomon Islands, [26]
All areas 2000 57.4 per 1,000 Clinic/hospital
reports MOH, Solomon Islands, [26]
All areas 2001 46.8 per 1,000 Clinic/hospital
reports MOH, Solomon Islands, [26]
All areas 2002 49.0 per 1,000 Clinic/hospital
reports MOH, Solomon Islands, [26]
All areas 2003 65.4 per 1,000 Clinic/hospital
reports MOH, Solomon Islands, [26]
All areas 2004 50.7 per 1,000 Clinic/hospital
reports MOH, Solomon Islands, [26]
All areas 2005 47.6 per 1,000 Clinic/hospital
reports MOH, Solomon Islands, [26]
All areas 2006 42.2 per 1,000 Clinic/hospital
reports MOH, Solomon Islands, [26]
All areas 2007 39.2 per 1,000 Clinic/hospital
reports MOH, Solomon Islands, [26]
∗The number of persons examined/screened.
1Deﬁnite cases: papillomatous or ulceropapillomatous.
2Suspected cases: scanty macules and maculopapulomatous.
3Rates of disease are calculated per 1,000 populations by dividing the number of cases of disease reported by the population in each age group and multiplying
by 1,000.
foundinFiji(28.81%).TheresultsaresummarizedinTable 6
[29]. Based on the results of these surveys, selective or mass
treatment with PAM was implemented, and the disease was
nearly eliminated in these countries by the 1960s. Passive
surveillance continued in these areas, and a very small
number of cases were reported over the next few decades.
Between 1969 and 1984, Fiji reported three cases, thought
to be the very last in that country. The last reports of yaws in
Tongawere7casesin1976.IntheCookIslands,anationwide
eradication campaign in 1960 covering approximately 99%
of the population found 17 cases of infectious yaws and
14 cases of noninfectious yaws [15]. No case has been10 Journal of Tropical Medicine
Table 5: Summary of yaws reported cases and prevalence surveys in Vanuatu since 1958.
Area Year Prevalence N∗ Activity type Reference
All areas except Tanna
Island 1958 —
94% of
population
(estimated)
Mass treatment Geizer, [15]
Tanna Island, TAFEA 1985 495 cases reported —
Cases reported from
clinic/hospital, followed
by mass treatment of
villages in North
Western Tanna
Harris et al., [27]
Tanna 1988-89
Clinical 16.5%
34 of 97 clinical cases
were VDRL positive
704
Preliminary
investigation prior to
mass treatment
13 villages and 1 school
Harris et al., [27]
Tanna 1989
Clinical 1.9%
32 of 189 clinical cases
were VDRL positive
18,213
Screening concurrent
with mass treatment of
∼90% of Tanna Island
population
Harris et al., [27]
Santo, SANMA 2000
21 clinical cases
2 0o u to ft h e2 1c a s e s
VDRL positive
—
Preliminary
investigation prior to
population sample
survey
Yaws mass campaign SANMA
province, ﬁnal report, [47]
Santo, SANMA 2000 VDRL positive 20.9% 273
Sample survey,
representative of Santo
Island
Yaws mass campaign SANMA
province, ﬁnal report, [47]
SANMA 2001
Clinical 0.7% (96 out
of 230 clinical cases
were VDRL positive)
36,414
Screening concurrent
with mass treatment of
92.4 + % of SANMA
province population
De Noray et al., [17]
Tanna 2007-08
789 suspected cases in
2007
187 suspected cases in
2008
—
Health
center/hospital-based
cases
Yaws prevalence survey, Tanna
Island, Report, [54]
Tanna 2008 31% positive RDT
and/or RDT 306 Sample survey (30 by 7) Fegan et al., [28]
∗The number of persons examined/screened.
Table 6: Prevalence of yaws pre- and postmass treatment in the 1950s and 1960s in Paciﬁc countries [26].
Country/area
Prevalence of active yaws (infectious yaws) %
Initial survey in the 50s Resurvey in the 60s
Cook Islands Not available 0.21 (0.01)
Fiji 28.81 (5.86) 0.00
Gilbert and Ellice Islands 2.21 (0.56) —∗
Tonga 2.20 (0.03) 0.01 (0.01)
Western Samoa 11.0 (2.90) 0.00 (0.00)
∗No survey carried out or considered necessary.
documented in these areas of the South Paciﬁc in recent
years. Data on past yaws control eﬀorts in remaining areas
of the South Paciﬁc are very limited.
3.7. Yaws in the Rest of the Western Paciﬁc Region
and in Neighboring Countries
3.7.1. Western Paciﬁc Region. The national control programs
were established in Cambodia, Laos, Malaysia, and the
Philippines in the 1950s. A signiﬁcant reduction of preva-
lence to near elimination was found during the resurveys in
the 1960s [29]. Little information on yaws after the 1960s
is available from these countries. However, in 1985, Lo
reviewed yaws control activities since the 1950s in Malaysia
[48] and concluded that the program has been a success and
that yaws disappearance from Malaysia could be expected.
In the following years, only a small outbreak consisting of
10 active cases was reported in Baling, Malaysia in 1989 [49],Journal of Tropical Medicine 11
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Figure 1: Yaws prevalence in the Western Paciﬁc Region in the 1950s.
and6imported casesofyawswerefoundinafamilyinJohor,
Malaysia, in 1988 [50].
In Australia, the most recent information we found is
from Garner et al. [51] who reported in 1972 results from
a serological survey in the aboriginal population of the
Northern Territory. They concluded that while no case of
active treponemal infection was found, the prevalence of
treponemal infection varied from 3.4% to 58% indicating
that yaws, endemic syphilis, and probably venereal syphilis
were present in the aboriginal population.
Figures 1, 2, 3,a n d4 summarize the prevalence of yaws
for the WPR from the 1950s to the present time.
3.7.2. South East Asia Region. Yaws remains endemic in parts
of Indonesia and Timor-Leste. In Indonesia, nearly 98% of
cases reported in 2003 were from the provinces of East Nusa
Tenggara, South East Sulewasi, Papua, and Maluku [52].
In Indonesia, yaws control became integrated with sexually
transmitted disease control in 1980, further with the leprosy
program in 2000, and then with the water and sanitation
program in 2003. In the early 2000s, the reported annual
incidence ranged from 2,000 to 4,500 cases [53]. In Timor-
Leste, the disease has been reported from at least 6 of 13
districts in recent years [53]. Yaws control is currently part
of an infectious disease control program targeting leprosy,
lymphatic ﬁlariasis, and soil-transmitted helminthiasis. The
estimated incidence of yaws in Timor-Leste ranges from 500
to 1,000 cases per year.
In both Indonesia and Timor-Leste, the assessment of
incidence relies on reports from primary health facilities;
therefore,thereportedincidencesmaynotbeaccuratedueto
underreporting or overdiagnosis. Obtaining greater political
commitment and suﬃcient resources has been a key chal-
lenge for strengthening the existing yaws control programs
in these countries.
India declared yaws elimination in 2006, after an absence
of yaws cases since 2004 [30]. The Yaws Eradication Pro-
gramme in India commenced in 1996 as a pilot program
following the development of an eradication strategy by
the National Institute of Communicable Disease and was
expanded to all endemic areas of the country in 1999.
The strategy consisted of two core activities: (1) active case
detection and treatment of cases and contacts with long-
acting penicillin and (2) community mobilization to raise
awareness through Information Education Communication
programs. The program was phased into three stages
(attack, maintenance, and elimination/eradication) and had
well-deﬁned criteria for elimination (nil reporting of new
infectious cases) and eradication (noseroactivity to RPR or
VDRL in children below 5 years of age after achieving “nil”
reporting for three years) as well as certiﬁcation processes
[53]. Four appraisals were conducted in 2000, 2002, 2004,12 Journal of Tropical Medicine
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Figure 2: Yaws prevalence in the Western Paciﬁc Region in the 1960s.
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Figure 4: Yaws prevalence in the Western Paciﬁc Region in the 1990s–present.
and2006,eachconductedbyanindependentteamconsisting
of a public health expert, a dermatologist, and a micro-
biologist. In addition to careful and detailed planning of
programactivities,factorsthoughttohavecontributedtothe
success include high-level political commitment maintained
throughout the campaign, advocacy for sustained com-
mitment, and the availability of resources. Rigorous active
case detection, where all suspected cases and contacts were
treated, was conducted biannually. Supportive monitoring
and supervision of peripheral health workers also assured
the high quality of case detection and helped to maintain
their motivation throughout the campaign. Following the
declaration of elimination in India, the WHO South-East
Asia Region has set 2012 as a target of yaws elimination from
Indonesia and Timor-Leste.
4. Conclusions
After the successful eradication campaigns of the 1960s, the
primary health care systems were supposed to give the last
push towards eradication of yaws. However, a combination
of various factors including poor political commitment and
limited funding resulted in a missed opportunity and dis-
appointed the hopes raised half a century ago.
Yaws presents new challenges such as poor awareness and
knowledge among health care workers, unknown epidemio-
logical situation, and attenuated clinical forms of the disease.
These challenges, combined with the current competing
priorities in the public health arena, require new, innovative,
and country-tailored approaches.
Recent experience in India as well as past experiences
in the South Paciﬁc clearly demonstrate that with a well-
designed elimination strategy based on reliable epidemiolog-
ical data and sustained high-level political commitment, it is
possible to eliminate yaws.
The increased attention required to address the resur-
g e n c eo fy a w si nt h ea ﬀected countries does not necessarily
mean increased resources. In view of the many health pri-
orities and the human and ﬁnancial resources constraints,
it rather calls for new and innovative approaches. Today,
utilization of existing programs with similar primary target
population (i.e., children under 15 years of age) in imple-
menting yaws control activities may provide a cost-eﬀective
option. For example, yaws screening and detection could be
included in school-based health promotion programs such
as a deworming program for soil-transmitted helminthiasis
or dental surveys. Cost-eﬀective strategies in identifying
cases, in providing treatment, and in tracing all contacts
need to be identiﬁed at country level in order to take
intoaccountlogisticalconstraints,resourcesavailablelocally,
and other health priorities in the aﬀected countries. Many
opportunities to revitalize yaws control activities already
exist at country level: Maternal and Child Health clinics and14 Journal of Tropical Medicine
their related activities, water and sanitation programmes, or
school-based programmes are such examples. One way to
approach yaws control might be to address it in the broader
context of the Primary Health Care (PHC) where lessons
learnt from past failures would be used to avoid repeating
the same mistakes. Yaws control activities could be powerful
tools for revitalizing and/or strengthening PHC in endemic
countries, especially if they use the momentum usually
created by mass campaigns, which are still necessary to bring
down the level of transmission in highly endemic areas. Such
an approach may mean that yaws eradication will take longer
than with repeated mass campaigns, but considering the
competing health priorities and other challenges faced by
the aﬀected countries, it might be a more sustainable and
realisticstrategy.Italsomeansthatbeforeamasscampaignis
considered due consideration must be given to the role of the
PHCsystembefore,during,andafterthecampaigniscarried
out.
However, at this stage it is of tremendous importance
to get a better understanding of the current epidemiological
situation through a strong and systematic assessment of
yaws in the Paciﬁc in general and in PNG, Vanuatu, and
Solomon in particular. Only then, sound strategies towards
elimination of yaws can be developed, and the work started
m o r et h a nh a l fac e n t u r ya g oc a nb ec o m p l e t e d .
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